Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
Clinical trial NCT03739125 · COMPLETED
Trial details
- NCT number
- NCT03739125
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2020-05-25
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.